Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)
Titel:
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)
Auteur:
Metaxas, Y. Früh, M. Eboulet, E.I. Grosso, F. Pless, M. Zucali, P.A. Ceresoli, G.L. Mark, M. Schneider, M. Maconi, A. Perrino, M. Biaggi-Rudolf, C. Froesch, P. Schmid, S. Waibel, C. Appenzeller, C. Rauch, D. von Moos, R.